Machine learning has revolutionized the field of biomedical research, enabling faster and more accurate development of algorithms that improve medical outcomes. Biomedical researchers are using machine learning tools and algorithms to analyze vast and complex health data to quickly identify patterns and relationships that were previously difficult to discern.
get to know the lab, an emerging developer of non-invasive medical diagnostic technology, is preparing a breakthrough in non-invasive blood glucose monitoring that could positively impact the lives of millions of people. One of the key elements behind this technology is the ability to process large amounts of new data generated by Bio-RFID™ radio frequency sensors using the following machine learning algorithms: edge impulse.
Benefits of medical machine learning
One of the key ways machine learning can improve algorithm development in the biomedical field is by developing more accurate predictions and insights. Machine learning algorithms use advanced statistical techniques to identify correlations and relationships that are not apparent to human researchers.
Machine learning algorithms can analyze a patient’s entire medical history and provide predictions about potential health outcomes, helping medical professionals intervene early to prevent disease progression. Machine learning algorithms can also be used to develop more personalized treatments.
Historically, this process has been time-consuming and error-prone due to the difficulty of managing large datasets. Machine learning algorithms, on the other hand, can quickly and easily process vast amounts of data and identify patterns without human intervention, thus reducing manual workload and errors.
The future of improving healthcare with machine learning
As machine learning technologies and use cases continue to grow, it is clear that unlocking the potential of large biomedical and patient datasets will help enable a future of improved healthcare.
Already, the early use of machine learning in diagnosis and treatment has led to the diagnosis of breast cancer from X-rays, the discovery of new antibiotics, the prediction of gestational diabetes onset from electronic health records, and the identification of patients with shared molecular signatures of treatments. It is shown that cluster identification can be expected. response.
According to a report that 400,000 hospitalized patients experience some kind of preventable medical error each year, machine learning can help predict and diagnose disease at a faster rate than most medical professionals, generating about $20 billion annually. can save
Companies like Linus Health, Viz.ai, PathAI, and Regard demonstrate the ability of artificial intelligence (AI) and machine learning (ML) to reduce errors and save lives.
Advances in patient care, including telephysiologic monitoring and care delivery, highlight the growing demand for the use of technology to enhance non-invasive means of medical diagnosis.
One important area where this advantage can be expected is non-invasive blood glucose monitoring without the need for a finger prick. This is important for the patient to effectively manage her type 1 and type 2 diabetes. Glucose biosensors have existed for more than half a century, but there are two groups: electrochemical sensors, which rely on direct interaction with the analyte, and electromagnetic sensors, which utilize antennas or resonators to detect changes in the dielectric properties of blood. can be classified into
The use of smart devices basically involves using optical sensors to shine light onto the body and quantify how that light is reflected to measure certain metrics. There are already smartwatches, fitness trackers and smart rings from companies like: Apple. AAPL, Samsung Electronics Co., Ltd. (KRX: 005930) and Google (Alphabet Inc. Google ) measures heart rate, blood oxygen level and many other metrics.
However, applying this technology to blood glucose measurements is much more complex and the data may not be accurate. Know Labs appears to be on track to solve this challenge.
Using machine learning to enhance bio-RFID technology
The Seattle-based company has partnered with Edge Impulse, a provider of machine learning development toolkits, to interpret robust data from its proprietary Bio-RFID technology. The algorithmic refinement process provided by Edge Impulse is an important step for interpreting existing large and novel datasets, ultimately supporting large-scale clinical studies.
Bio-RFID technology is a non-invasive, novel radio frequency sensor that can safely see through the entire cell stack and accurately identify the unique molecular signatures of a wide range of organic and inorganic materials, molecules and compositions. medical diagnostic technology. of substance.
Microwave and radio frequency sensors operate over a wider frequency range, requiring much broader data sets that require advanced algorithm development. In collaboration with Know Labs, Edge Impulse uses machine learning tools to train a neural network model to interpret this data and predict blood glucose levels using his CGM proxy for blood glucose levels in general. . Edge Impulse provides a user-friendly approach to machine learning, enabling product developers and researchers to optimize sensory data analysis performance. This technology builds on his AutoML and TinyML to make AI more accessible and enable fast and efficient machine learning modeling.
Know Labs, a company committed to changing people’s lives by developing convenient, affordable, non-invasive medical diagnostic solutions, and tools that enable the creation and deployment of advanced AI algorithms. Our partnership with manufacturer Edge Impulse is a prime example. On how responsible machine learning applications can greatly improve and transform medical diagnostics.
Featured photo by JiBJhoY on Shutterstock
This post contains sponsored advertising content.This content is for informational purposes only and is not intended as investment advice
